Color raises further $75-million funding
Color – a health technology and precision genomics firm – has raised US$75 million in a series D funding round, and is collaborating with Sanford Health to further enhance its programme offering
Led by T. Rowe Funds and Viking Global Investors, the funding allowed Color to accrue a number of new partners, which now comprise Apple, Verily, Northshore University HealthSystem, the Teamsters Health and Welfare Fund of Philadelphia and Vicinity, and Sanford Health.
Color has also announced that it is now working alongside not-for-profit healthcare system Sanford Health to build on its Imagenetics genomics programme, which will, in turn, allow Sanford Health to embed genetic medicine directly into primary care, as well as to implement Color’s digital tools to engage patients and streamline clinical reporting within its facilities.
Caroline Savello, Vice-President of Commercial for Color, commented: "In the last 18 months, we saw a huge acceleration with institutions around the world and across every type of player in the health ecosystem – whether it’s hospitals or health systems, large-scale research programmes, payers, care delivery or employers – who want to change the care delivery model for their population by understanding genetics across the population.”